Status:
COMPLETED
Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
Aim 1. Determine the impact of a daily, automated telephone intervention on HbA1c levels compared to standard care in older patients with type 2 diabetes. Aim 2. Determine the impact of the automated...
Eligibility Criteria
Inclusion
- Age greater or equal to 55
- Type 2 diabetes
- English speaking
- Ability to use glucose meter
Exclusion
- Unable to give informed consent
- Unwilling to allow SMBG levels to be shard with primary care physician
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00700908
Start Date
June 1 2007
End Date
June 1 2008
Last Update
February 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Care Center University of Minnesota
Minneapolis, Minnesota, United States, 55455